
Kimberly Brown
Company President
Kimberly Brown is the President of Innova Pharmaceuticals, where she leads the company’s tactical operations and expands drug import opportunities. She also serves as President of IP SecureTech, LLC, directing national and international projects in industrial development, data centers, and biotech ventures.

Chris McElvany
CEO
Chris McElvany, a serial entrepreneur and private equity investor, serves as CEO of Innova Pharmaceuticals. He has co-founded and scaled Lucy Scientific Discovery (IPO $65.4M) and OrganaBrands (sold into SLANG Worldwide for $226M), and focuses on drug shortages and decentralizing pharmaceutical supply chains.
WS
William Steuer
Senior Director, International Strategy and Trade
William Steuer, a retired Senior Foreign Service officer from the U.S. Department of State, brings decades of diplomacy and high-stakes negotiation experience. Holding an active federal security clearance, he advises Innova on foreign investment, geopolitics, and cross-border operations.

Jonathan Smokler
Chief Operating Officer
Jonathan Smokler is Chief Operating Officer of Innova Pharmaceuticals, responsible for day-to-day operations and execution across the company’s distribution and partnership work.
HQ
Huy Q. Phung, Ph.D
CEO, BlueBio Pte Ltd. Asia
Dr. Huy Phung leads BlueBio USA and BlueBio Asia with 27 years of expertise in pharmaceutical supply chains and formula design, with academic affiliations at MIT, Princeton, and Ho Chi Minh University.
MD
Mark Depew
CEO, EcomBlue LLC
Mark Depew is CEO of EcomBlue LLC, focused on affordable pharmaceuticals for consumers, with 35+ years in startups, capital raising, logistics, and regulatory compliance.
MA
Minh A. Tran
Senior Executive, Biopharmaceutical Strategy
Minh Tran has 30+ years in biopharmaceuticals and biologics. Former Global Head of Commercial for Automation, PAT, and Digital Solutions at Merck KGaA, he now focuses on manufacturing capability and partnerships across Asia.